Invention Grant
- Patent Title: Cytotoxic agents comprising new maytansinoids
-
Application No.: US11778451Application Date: 2007-07-16
-
Publication No.: US08435528B2Publication Date: 2013-05-07
- Inventor: Ravi V. J. Chari , Wayne C. Widdison
- Applicant: Ravi V. J. Chari , Wayne C. Widdison
- Applicant Address: US MA Waltham
- Assignee: ImmunoGen, Inc.
- Current Assignee: ImmunoGen, Inc.
- Current Assignee Address: US MA Waltham
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Yu Lu
- Main IPC: A61K39/395
- IPC: A61K39/395

Abstract:
New thiol and disulfide-containing maytansinoids bearing a mono or di-alkyl substitution on the α-carbon atom bearing the sulfur atom are disclosed. Also disclosed are methods for the synthesis of these new maytansinoids and methods for the linkage of these new maytansinoids to cell-binding agents. The maytansinoid-cell-binding agent conjugates are useful as therapeutic agents, which are delivered specifically to target cells and are cytotoxic. These conjugates display vastly improved therapeutic efficacy in animal tumor models compared to the previously described agents.
Public/Granted literature
- US20070269447A1 CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS Public/Granted day:2007-11-22
Information query